Radical Numerics CEO calls the handling of its AI-designed phage announcement a mistake after its partner disagreed over disclosure
Radical Numerics · Company post
Read the source (opens in a new tab)- What happened
- Eric Nguyen, co-founder and CEO of Radical Numerics, posted a note on November 9, 2026 about the company's phage work with Tabula Bioscience, responding to public discussion involving Tabula and George Church.
- Key points
- He says the two companies "had different perspectives on when and how to share this milestone, including public concerns around AI, biosecurity, and the number of clinical cases."
- Radical "believed the broader implications of this new capability in genome design warranted earlier disclosure rather than later," he writes, and understood Tabula no longer wanted to co-announce.
- He says Radical should have communicated more directly and ensured all partners' contributions were represented: "This was a mistake." It is setting clearer expectations on attribution and communication.
- He says Tabula "played a leading role in the broader effort"; Radical's part was phages designed with its genome language models, included in a cocktail given to a patient under compassionate use.
- Evidence
- The CEO's own post on the company blog. It does not say which company raised the biosecurity concerns or what they were, and gives no clinical outcome or new data.
- Uncertain
- The note gives only Radical's side; Tabula Bioscience's account was not reviewed for this entry.